Diversified Energy (DEC) had the highest return between August 1, 2023 and January 31, 2024 by a small-cap US stock, returning 859.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Diversified Energy (DEC) | 8/1/2023 - 1/31/2024 | 859.36% |
Akso Health Group ADR (AHG) | 8/1/2023 - 1/31/2024 | 541.13% |
Silence Therapeutics (SLN) | 8/1/2023 - 1/31/2024 | 284.79% |
Shattuck Labs (STTK) | 8/1/2023 - 1/31/2024 | 268.75% |
Crexendo (CXDO) | 8/1/2023 - 1/31/2024 | 265.03% |
Neuropace (NPCE) | 8/1/2023 - 1/31/2024 | 252.29% |
Invivyd (IVVD) | 8/1/2023 - 1/31/2024 | 228.97% |
Altimmune (ALT) | 8/1/2023 - 1/31/2024 | 181.79% |
Sky Harbour (SKYH) | 8/1/2023 - 1/31/2024 | 174.42% |
Energy Services Of America (ESOA) | 8/1/2023 - 1/31/2024 | 173.36% |
M-tron Industries (MPTI) | 8/1/2023 - 1/31/2024 | 165.53% |
Brainsway (BWAY) | 8/1/2023 - 1/31/2024 | 160.83% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 8/1/2023 - 1/31/2024 | 155.4% |
Biohaven Pharmaceutical (BHVN) | 8/1/2023 - 1/31/2024 | 125.67% |
Taysha Gene Therapies (TSHA) | 8/1/2023 - 1/31/2024 | 122.55% |
Neurogene (NGNE) | 8/1/2023 - 1/31/2024 | 121.76% |
American Coastal Insurance (ACIC) | 8/1/2023 - 1/31/2024 | 120.8% |
Ardelyx (ARDX) | 8/1/2023 - 1/31/2024 | 120.45% |
Eyepoint Pharmaceuticals (EYPT) | 8/1/2023 - 1/31/2024 | 118.06% |
Gyre Therapeutics (GYRE) | 8/1/2023 - 1/31/2024 | 117.02% |
American Public Education (APEI) | 8/1/2023 - 1/31/2024 | 112.02% |
Ramaco Resources (METC) | 8/1/2023 - 1/31/2024 | 110.98% |
ASP Isotopes Inc Common Stock (ASPI) | 8/1/2023 - 1/31/2024 | 109.4% |
ADC Therapeutics (ADCT) | 8/1/2023 - 1/31/2024 | 109.4% |
MMTEC (MTC) | 8/1/2023 - 1/31/2024 | 106.29% |
Small-cap stocks are treated as having a market cap between $300M and $2B.